Serological Evidence of Herpes Simplex Virus Type 2 IgM Antibody among Expectant Mothers Attending a Tertiary Healthcare Facility in Port Harcourt, Nigeria
Published: 2023-12-18
Page: 442-450
Issue: 2023 - Volume 6 [Issue 1]
Okonko I. O.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Awah A.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Omang P. A.
Department of Microbiology, University of Calabar, Calabar, Cross River State, Nigeria.
Cookey T. I. *
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Okonko, B. J.
Department of Applied Microbiology, Virology and Immunology Research Unit, Ebonyi State University, Abakaliki, Nigeria.
Onu E. N.
Department of Medical Microbiology, Faculty of Basic Clinical Medicine, Alex -Ekwueme Federal University Ndufu-Alike, Ikwo, Ebonyi State, Nigeria.
Oketah, E. N.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Innocent-Adiele H. C.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Adim C. C.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
Amadi, B. O.
Department of Microbiology, Virus and Genomics Research Unit, University of Port Harcourt, Port Harcourt, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Herpes simplex virus (HSV) is the common viral infection that causes herpes and for which there is now no known cure. The two subtypes, HSV-1 and HSV-2, are known to induce a wide range of symptoms, from acute to long-term. HSV infections typically do not cause any symptoms, yet they can be fatal to expectant mothers and their unborn children. The purpose of this study is to look into the serological evidence of herpes simplex virus 2 IgM antibodies in expectant mothers in a tertiary healthcare facility in Port Harcourt, Rivers State, Nigeria.
Study Design: Ninety expectant mothers who visited the antenatal clinic at a tertiary health facility in Port Harcourt, Nigeria, were randomly analyzed as part of a hospital-based cross-sectional study.
Place and Duration of Study: The University of Port Harcourt Teaching Hospital (UPTH), in Rivers State, Nigeria from January 2019 to November 2019.
Methods: The HSV-2 IgM antibodies in the collected samples were evaluated using the Enzyme-Linked Immunosorbent Assay (ELISA). The method was followed as directed by the manufacturer. The relationship between the infection and sociodemographic variables was evaluated using chi-square analysis.
Results: Of the 90 expectant mothers, two (2.2%) had HSV-2 IgM antibody seropositive, and forty-four (48.1%) had HSV-2 IgM antibody seronegative. There was no significant correlation (p>0.05) found between the sociodemographic characteristics examined and the prevalence of HSV-2 IgM antibodies. Age groups 20–29 years old (4.7%), married (2.2%), pregnant women with tertiary education (2.6%), traders (6.5%), Christians (2.5%), monogamous family type (2.5%), pregnant women in their second trimester (4.5%), nulliparous (3.0%), history of abortion (3.3%), and history of STDs (16.7%) were found to have higher prevalence of HSV-2 IgM antibody.
Conclusions: The 2.2% prevalence of HSV-2 IgM antibodies obtained in this study further confirms the occurrence of primary or recurrent HSV-2 infection in pregnant women. According to the study, there was a substantial correlation between a history of sexually transmitted diseases (STDs) and the prevalence of HSV-2 IgM. This finding makes it necessary for all expectant mothers to have a serological assessment for HSV antibodies to detect early and treat congenital infections in the fetus as soon as possible. To manage the viral seropositivity observed in expectant mothers in Port Harcourt, Nigeria, screening for herpes simplex viruses is advised.
Keywords: HSV-2, prevalence, IgM, ELISA, UPTH
How to Cite
Downloads
References
Xu X, Zhang Y, Li Q. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development. Rev. Med. Virol. 2019;29:e2054
Nath P, Kabir MA, Doust SK, Ray, A. Diagnosis of herpes simplex virus: Laboratory and Point-of-Care Techniques. Infect. Dis. Rep. 2021;13:518–539. Available:https://doi.org/10.3390/idr13020049
Hammad WAB, Konje C. Herpes simplex virus infection in pregnancy – An update. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2021;259:38-45.
Hosseini SD, Yasaghi M, Mobasheri E, Razavi Nikoo H, Tabarraei A. Molecular and Serological Epidemiology of Herpes Simplex Virus Type 1 and 2 in Pregnant Women of Gorgan City, North East of Iran. Journal of reproduction & Infertility. 2023;24(1):35–42. Available:https://doi.org/10.18502/jri.v24i1.11907
Oluboyo BO, Fayuko OP, Akele RY, Akinseye FJ, Oluboyo AO. Prevalence of herpes simplex virus type 2 antibodies among pregnant women attending federal teaching hospital, Ido-Ekiti, Nigeria. World Journal of Advance Research and Review. 2020;6(1):200-206.
Whitley R, Baines J. Clinical management of herpes simplex virus infections: Past, present, and future. F1000Res. 2018;7. Available:https://doi.org/10.12688/f1000research.16157.1
Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Newman LM, Gottlieb SL. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob. Health. 2017;5 (3):e300-e309. Available https://doi.org/10.1016/S2214-109X(16)30362-X
Sert UY, Ozgu-Erdinc AS, Saygan S, Engin-Ustun Y. Herpes simplex infection during pregnancy, results of a tertiary referral centre in Turkey. Z Geburtshilfe Neonatol. 2020;224(1):22–5.
Wang C, Zhou YH, Yang HX, Poon LC. Intrauterine vertical transmission of SARS-CoV-2: What we know so far. Ultrasound Obstet Gynecol. 2020;55(6):724–5.
Khardr L, Harfouche M, Omori R, Schwarzer G, Chemaitelly H, Abu-Raddad LJ. The epidemiology of herpes simplex virus type 1 in Asia: Systematic review, meta-analyses, and meta-regressions. Clin Infect Dis. 2019;68(5):757–72.
Allen UD, Robinson JL, Bitim A, McDonald J. Prevention and management of neonatal herpes simplex virus infection. Canadian Paediatrics Society Infectious Disease and Immunization Committee. 2020;9:310-334.
Ugadu IO, Nwuzo AC, Ugbo EN, Njoku OM, Njoku CJ, Ayomoh EE. Seroprevalence of Herpes Simplex Virus Type-1 and 2 among Pregnant Women Attending Antenatal Care at Mile Four Hospital, Abakaliki, Ebonyi State, Nigeria. Nigerian Journal of Microbiology. 2022;36(1):6190 – 6197.
Shi TL, Huang LJ, Zhong YY, Yang JJ, Fu T, Lei XF, Chen Q. The risk of herpes simplex virus and human cytomegalovirus infection during pregnancy upon adverse pregnancy outcome. Meta-analysis. Journal of Clinical Virology. 2018;104:48-55.
Tookey PA, Mahdavi S, Peckham CS. Surveillance of neonatal herpes in the British Isles 2004–2006. F1000Research. 2020;9(163):163.
Yu W, Hu X, Cao B. Viral infections during pregnancy: The big challenge threatening maternal and fetal health. Journal of Maternal-Fetal Medicine. 2021;4(1) 72-86.
Aaoye MO, Olokoba AB, Oluwole AA, Olowookere SA : Prevalence and correlates of herpes simplex virus type 1&2 among pregnant women attending a tertiary hospital in Nigeria. Journal of Clinical and Experimental Microbiology. 2021;22(1) 63-70.
Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, et al. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period. BMC Infect Dis. 2016;16:364.
Kozel TR, Burnham-Marusich AR, Point-of-Care Testing for Infectious Diseases: Past, Present, and Future. J. Clin. Microbiol. 2017;55:2313–2320
Ray A, Daloglu, MU, Ho J, Torres A, Mcleod E, Ozcan A. Computational sensing of herpes simplex virus using a cost-effective on-chip microscope. Sci. Rep. 2017;7:4856.
Li C, Li Y, Yang Y, Wang J, Zhu C, Tang S, Pang C, Tang W, Cai Q.; Li Z et al. The detection and characterization of herpes simplex virus type 1 in confirmed measles cases. Sci. Rep. 2019;9:12785
Muller WJ, Zheng X. Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections. J. Clin. Microbiol. 2019;57: e01460-18.
Okonko IO, Cookey TI. Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria. Journal of African Health Science. 2015;15(3):737-747.
Alaa T, Abdel-Rahim ME, Azza B, Isam ME, Khalid A. Molecular detection of Herpes virus type 1&2 among pregnant women in Khartoum state, Sudan International Journal of Scientific Research in Science, Engineering and Technology 2019;4(10):2394-4099.
Mahmood, M.N., and Najem, M.H., 2020. Detection of infection by Toxoplasma and Herpes simplex virus 2 among women exposed to abortion in Ninavah province/ Iraq. Tikrit J. Pure Sci. 2020;25(4): 31-35.
Abdulkhaliq RJ, Mohammed ST, Abbas AAH, Seroprevalence of rubella, cytomegalovirus, herpes, and Toxoplasma gondii in recurrent aborted women in Baghdad. Pak. J. Biotechnol. 2017;14(3): 359-364.
Amar OAO, Bajaj HK, Gupta N, Singla A, Masih H, Prevalence of herpes simplex virus in pregnant women from Gangetic plain region of Allahabad, India. Adv. Microbiol. 2015;5(6):404. Available:https://doi.org/10.4236/aim.2015.56041
Al-Hakami AM, Paul E, Al-Abed F, Alzoani AA, Shati AA, Assiri MI, Chandramoorthy HC.. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia. Saudi Med. J. 2020;41(7):757.
Available:https://doi.org/10.15537/smj.2020.7.25121
Ozdemir M, Kalem F, Feyzioğlu B, Baysal B,. Investigation of viral pathogens during pregnancy in a city region in Turkey. Anatol. J. Clin. Investig. 2011;5:78-81.
El-Amin EO, Elamin OE, Ahmed RAM, Abdulla AK, Elamin SE, Elhaj HI. Sero-prevalence of herpes virus infection in Sudanese pregnant women. Trop. Med. Health Surg. 2013;1:1-4.
Rajendiran P, Saravanan N, Ramamurthy M, Sankar S, David N, Nair A, Sridharan G. Seroprevalence of TORCH‑S infections among pregnant woman: A study from Vellore District (South India). Med. Glob. Surv. 2021;12(2):170-170.
Available:https://doi.org/10.4103/jnsbm.JNSBM_103_20
Abbai NS, Govender S, Nyirenda M. Herpes simplex virus-2 infections in pregnant women from Durban, South Africa: prevalence, risk factors and co-infection with HIV-1. South African J Infect Dis. 2018;33(5):1–7.
Sharma P & Ganga RT. A study to assess the prevalence of Herpes simplex type 2 (HSV-2) infections in pregnant women in a tertiary care hospital. Int J Health Sci. 2022;6(S1):11938–45.
Mezher MN, Mejbel FA, Hussein HK. Detection of Herpes Simplex-2 Virus in Women with Spontaneous Abortion in Al-Najaf City/Iraq. J Pharm Sci Res. 2018;10(1):110–13.
Okonko IO, Cookey TI, Okerentugba PO, Frank-Peterside N. Serum HSV-1 and -2 IgM in Pregnant Women in Port Harcourt, Nigeria, Journal of Immunoassay and Immunochemistry. 2015;36(4):343- 358.
Saheduzzaman M, Sharmin Z, Al Hossain A, Hoque MM, Das MK, Rahman MA. Relation of IgM antibody with Herpes simplex virus type-2 among women with spontaneous abortion and normal delivery. J Brahmanbaria Med College. 2021;3(2):14–17.
Alkharash KR, Wanni NH, Reem Al Dossary RA, Obeid OE, Hunasemarada BC, Qahtani NA, El-Badry AM. Prevalence of herpes simplex virus 1&2 antibodies among individuals screened in a tertiary hospital in Eastern province of Saudi Arabia Journal of Medicine and Life. 2022;15(10):1272-1277.
Lima LR, Dos-Santos PJDS, De Almeida NA, De Meneses MD, Aguiar SF, Fernandes CA, de Paula VS. Seroprevalence of human alphaherpesvirus 1 and 2 among pregnant women infected or uninfected with Zika virus from Rio de Janeiro, Brazil. J. Med. Virol. 2021;93(6):3383-3388.
Available:https://doi.org/10.1002/jmv.26665
Mahant S, Hall M, Schondelmeyer AC, Berry JG, Kimberlin DW, Shah SS. Neonatal herpes simplex virus infection among Medicaid-enrolled children: 2009–2015. Pediatrics. 2019;143: 4):e20183233.
Nikolic D, Kohn D, Yen-Lieberman B, Procop GW. Detection of herpes simplex virus and Varicella-Zoster virus by traditional and multiplex molecular methods. Am. J. Clin. Pathol. 2019,151:122–126
Slinger R, Amrud K, Sant N, Ramotar K, Desjardins M. A comparison of the quidel solana HSV 1 + 2/VZV Assay, the focus diagnostics simplex HSV 1 & 2 direct assay and the luminex aries HSV 1&2 Assay for detection of herpes simplex virus 1 and 2 from swab specimens. J. Clin. Virol. 2019;113:35–38.